EXTENDING THE SUSCEPTIBLE-EXPOSED-INFECTED-REMOVED (SEIR) MODEL TO HANDLE THE HIGH <i>fa</i>LSE <i>n</i>EGATIVE RATE AND <i>sy</i>MPTOM-BASED ADMINISTRATION OF COVID-19 DIAGNOSTIC TESTS: <i>SEIR-fansy</i>
medRxiv (Cold Spring Harbor Laboratory)